• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于疏水相互作用的机制引发了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白与血管紧张素转换酶2(ACE2)之间的对接。

A Hydrophobic-Interaction-Based Mechanism Triggers Docking between the SARS-CoV-2 Spike and Angiotensin-Converting Enzyme 2.

作者信息

Li Jiacheng, Ma Xiaoliang, Guo Shuai, Hou Chengyu, Shi Liping, Zhang Hongchi, Zheng Bing, Liao Chenchen, Yang Lin, Ye Lin, He Xiaodong

机构信息

National Key Laboratory of Science and Technology on Advanced Composites in Special Environments Center for Composite Materials and Structures Harbin Institute of Technology Harbin 150080 P. R. China.

School of Electronics and Information Engineering Harbin Institute of Technology Harbin 150080 P. R. China.

出版信息

Glob Chall. 2020 Oct 15;4(12):2000067. doi: 10.1002/gch2.202000067. eCollection 2020 Dec.

DOI:10.1002/gch2.202000067
PMID:33173592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7646041/
Abstract

A recent experimental study found that the binding affinity between the cellular receptor human angiotensin-converting enzyme 2 (ACE2) and receptor-binding domain (RBD) in the spike (S) protein of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is more than tenfold higher than that of the original severe acute respiratory syndrome coronavirus (SARS-CoV). However, main chain structures of the SARS-CoV-2 RBD are almost the same with that of the SARS-CoV RBD. Understanding the physical mechanism responsible for the outstanding affinity between the SARS-CoV-2 S and ACE2 is an "urgent challenge" for developing blockers, vaccines, and therapeutic antibodies against the coronavirus disease 2019 (COVID-19) pandemic. Taking into account the mechanisms of hydrophobic interaction, hydration shell, surface tension, and the shielding effect of water molecules, this study reveals a hydrophobic-interaction-based mechanism by means of which SARS-CoV-2 S and ACE2 bind together in an aqueous environment. The hydrophobic interaction between the SARS-CoV-2 S and ACE2 protein is found to be significantly greater than that between SARS-CoV S and ACE2. At the docking site, the hydrophobic portions of the hydrophilic side chains of SARS-CoV-2 S are found to be involved in the hydrophobic interaction between SARS-CoV-2 S and ACE2.

摘要

最近的一项实验研究发现,新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突(S)蛋白中的细胞受体人血管紧张素转换酶2(ACE2)与受体结合域(RBD)之间的结合亲和力比原始严重急性呼吸综合征冠状病毒(SARS-CoV)高出十倍以上。然而,SARS-CoV-2 RBD的主链结构与SARS-CoV RBD几乎相同。了解SARS-CoV-2 S与ACE2之间出色亲和力的物理机制是开发针对2019冠状病毒病(COVID-19)大流行的阻滞剂、疫苗和治疗性抗体的“紧迫挑战”。考虑到疏水相互作用、水合壳、表面张力和水分子屏蔽效应的机制,本研究揭示了一种基于疏水相互作用的机制,通过该机制SARS-CoV-2 S和ACE2在水环境中结合在一起。研究发现,SARS-CoV-2 S与ACE2蛋白之间的疏水相互作用明显大于SARS-CoV S与ACE2之间的疏水相互作用。在对接位点,发现SARS-CoV-2 S亲水性侧链的疏水部分参与了SARS-CoV-2 S与ACE2之间的疏水相互作用。

相似文献

1
A Hydrophobic-Interaction-Based Mechanism Triggers Docking between the SARS-CoV-2 Spike and Angiotensin-Converting Enzyme 2.一种基于疏水相互作用的机制引发了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白与血管紧张素转换酶2(ACE2)之间的对接。
Glob Chall. 2020 Oct 15;4(12):2000067. doi: 10.1002/gch2.202000067. eCollection 2020 Dec.
2
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.竞争性 SARS-CoV-2 血清学研究表明,大多数针对刺突受体结合域的抗体竞争与 ACE2 结合。
mSphere. 2020 Sep 16;5(5):e00802-20. doi: 10.1128/mSphere.00802-20.
3
Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor.使用新型冠状病毒病-2019受体结合域1C适体通过抑制血管紧张素转换酶2受体的表达来预防新型冠状病毒病-2019病毒
J Adv Pharm Technol Res. 2023 Jul-Sep;14(3):185-190. doi: 10.4103/JAPTR.JAPTR_117_23. Epub 2023 Jul 28.
4
Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.SARS-CoV-2 刺突 RBD 与人 ACE2 蛋白-蛋白相互作用的生物力学特性分析。
Biophys J. 2021 Mar 16;120(6):1011-1019. doi: 10.1016/j.bpj.2021.02.007. Epub 2021 Feb 17.
5
Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的抑制剂筛选及其阻断病毒进入机制的能力:一项病毒信息学研究。
Saudi J Biol Sci. 2021 Jun;28(6):3262-3269. doi: 10.1016/j.sjbs.2021.02.066. Epub 2021 Feb 26.
6
Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.截短的人血管紧张素转换酶2;一种潜在的严重急性呼吸综合征冠状病毒2刺突糖蛋白抑制剂和有效的2019冠状病毒病治疗剂。
J Biomol Struct Dyn. 2021 Jul;39(10):3605-3614. doi: 10.1080/07391102.2020.1768150. Epub 2020 May 20.
7
Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein.基于五肽ATN-161的新冠病毒刺突蛋白中和机制
Biochem Biophys Rep. 2021 Dec;28:101170. doi: 10.1016/j.bbrep.2021.101170. Epub 2021 Nov 10.
8
The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.刺突蛋白-ACE2 结合分析:评估疫苗效力和筛选 SARS-CoV-2 抑制剂及中和抗体的体外平台。
J Immunol Methods. 2022 Apr;503:113244. doi: 10.1016/j.jim.2022.113244. Epub 2022 Feb 23.
9
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.一种新型治疗性肽可阻断 SARS-CoV-2 刺突蛋白与宿主细胞 ACE2 受体结合。
Drugs R D. 2021 Sep;21(3):273-283. doi: 10.1007/s40268-021-00357-0. Epub 2021 Jul 29.
10
Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.SARS-CoV-2 与人血管紧张素转化酶 2 受体热点残基相互作用的结构与模拟分析。
J Biomol Struct Dyn. 2021 Jul;39(11):4015-4025. doi: 10.1080/07391102.2020.1773318. Epub 2020 Jun 4.

引用本文的文献

1
Synthesis of new nicotintaldehyde derivatives via Pd(0) catalyzed suzuki coupling with structural characterization and co-combined computational-experimental evaluation against oral pathogens.通过钯(0)催化的铃木偶联反应合成新型烟碱醛衍生物及其结构表征,并针对口腔病原体进行计算-实验联合评估。
Sci Rep. 2025 Jul 1;15(1):22205. doi: 10.1038/s41598-025-05156-0.
2
Analysis of the anti-Alzheimer potential of bioactive compounds from DC. peel, leaf, and essential oil by network pharmacology.基于网络药理学对来自[植物名称](原文未完整给出植物学名)果皮、叶片和精油中生物活性化合物的抗阿尔茨海默病潜力分析。
Heliyon. 2024 Jun 26;10(13):e33496. doi: 10.1016/j.heliyon.2024.e33496. eCollection 2024 Jul 15.
3
Low-Entropy Hydration Shells at the Spike RBD's Binding Site May Reveal the Contagiousness of SARS-CoV-2 Variants.
刺突蛋白 RBD 结合位点处的低熵水合壳可能揭示 SARS-CoV-2 变体的传染性。
Biomolecules. 2023 Nov 7;13(11):1628. doi: 10.3390/biom13111628.
4
Raman Fingerprints of SARS-CoV-2 Omicron Subvariants: Molecular Roots of Virological Characteristics and Evolutionary Directions.SARS-CoV-2 奥密克戎亚型的拉曼指纹:病毒学特征和进化方向的分子根源。
ACS Infect Dis. 2023 Nov 10;9(11):2226-2251. doi: 10.1021/acsinfecdis.3c00312. Epub 2023 Oct 18.
5
Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2.释放鲨鱼可变单域(VNAR)的力量:抗击 SARS-CoV-2 的广谱中和工具。
Front Immunol. 2023 Sep 11;14:1257042. doi: 10.3389/fimmu.2023.1257042. eCollection 2023.
6
Spatial Layouts of Low-Entropy Hydration Shells Guide Protein Binding.低熵水合壳层的空间布局指导蛋白质结合。
Glob Chall. 2023 May 2;7(7):2300022. doi: 10.1002/gch2.202300022. eCollection 2023 Jul.
7
Binding behavior of spike protein and receptor binding domain of the SARS-CoV-2 virus at different environmental conditions. Spike 蛋白与 SARS-CoV-2 病毒受体结合域在不同环境条件下的结合行为。
Sci Rep. 2022 Jan 17;12(1):789. doi: 10.1038/s41598-021-04673-y.
8
Tracking the amino acid changes of spike proteins across diverse host species of severe acute respiratory syndrome coronavirus 2.追踪严重急性呼吸综合征冠状病毒2在不同宿主物种间刺突蛋白的氨基酸变化。
iScience. 2022 Jan 21;25(1):103560. doi: 10.1016/j.isci.2021.103560. Epub 2021 Dec 2.
9
SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape.SARS-CoV-2 变体、RBD 突变、结合亲和力和抗体逃逸。
Int J Mol Sci. 2021 Nov 9;22(22):12114. doi: 10.3390/ijms222212114.
10
Entropy-Enthalpy Compensations Fold Proteins in Precise Ways.熵焓补偿以精确的方式折叠蛋白质。
Int J Mol Sci. 2021 Sep 6;22(17):9653. doi: 10.3390/ijms22179653.